Skip to content

Clinical trials

Phase 1/2 Fallopian Tube Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20121
20141
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group2
AstraZeneca1
Clovis Oncology, Inc.1
Eli Lilly and Company1
Medical University Innsbruck1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms6
Ovarian Neoplasms4
Carcinoma, Ovarian Epithelial2
Endometrial Neoplasms2
Uterine Cervical Neoplasms2
Astrocytoma1
Breast Neoplasms1
Disorders of Sex Development1
Genital Neoplasms, Female1
Glioma1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.